BioSpace News Archive

Avinger, Inc. today announced presentations featuring the Company’s Lumivascular, OCT-guided, technologies at the annual AMP (Amputation Prevention Symposium) conference occurring last week.

Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced financial results for the second quarter ended June 30, 2021 and provided a corporate update.

Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today provides a business update and releases its financial results for the first fiscal quarter, ended June 30, 2021, of fiscal 2022.

Sino Biological, Inc., a biotechnology company which provides biological research reagents and related technical contract research services, announced a successful listing on the Shenzhen Stock Exchange subsidiary ChiNext under the stock abbreviation Sino Biological and stock code 301047.

The occurrence of psoriatic arthritis can place an extremely negative toll on the overall health of individuals.

More than 7000 types of rare diseases affect more than 30 million people in the U.S. alone. Approximately 80% of the rare diseases are found to be genetic.

The global infusion rate monitoring market is foreseen to gather exceptional sales opportunities during the forecast period of 2020 to 2030.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per insights by Fact.MR, the global market for multiphoton microscopy is expected grow at a CAGR of nearly 5% over the forecast period 2021-2031, owing to the increasing adoption of multiphoton microscopy in the cancer research centres.

The global market for antidiuretic drugs has been rising on account of advancements in the field of pharmaceutical formulations.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per a survey conducted by Fact.MR, the global influenza diagnostics market totaled US$ 2.5 billion in the year 2020, registering growth at a CAGR of 4% between 2016 and 2020.